These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 27130441)
21. Fluoxetine blocks Nav1.5 channels via a mechanism similar to that of class 1 antiarrhythmics. Poulin H; Bruhova I; Timour Q; Theriault O; Beaulieu JM; Frassati D; Chahine M Mol Pharmacol; 2014 Oct; 86(4):378-89. PubMed ID: 25028482 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142 [TBL] [Abstract][Full Text] [Related]
23. The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5. Schulze V; Stoetzer C; O'Reilly AO; Eberhardt E; Foadi N; Ahrens J; Wegner F; Lampert A; de la Roche J; Leffler A Br J Pharmacol; 2014 Jan; 171(2):427-37. PubMed ID: 24117196 [TBL] [Abstract][Full Text] [Related]
24. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine. Elajnaf T; Baptista-Hon DT; Hales TG Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221 [TBL] [Abstract][Full Text] [Related]
25. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23. John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698 [TBL] [Abstract][Full Text] [Related]
26. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat. Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265 [TBL] [Abstract][Full Text] [Related]
27. Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts. Mishra S; Reznikov V; Maltsev VA; Undrovinas NA; Sabbah HN; Undrovinas A J Physiol; 2015 Mar; 593(6):1409-27. PubMed ID: 25772296 [TBL] [Abstract][Full Text] [Related]
28. Isoform-selective effects of isoflurane on voltage-gated Na+ channels. OuYang W; Hemmings HC Anesthesiology; 2007 Jul; 107(1):91-8. PubMed ID: 17585220 [TBL] [Abstract][Full Text] [Related]
29. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels. Schwoerer AP; Scheel H; Friederich P Anesth Analg; 2015 Jun; 120(6):1226-34. PubMed ID: 25692452 [TBL] [Abstract][Full Text] [Related]
30. About half of the late sodium current in cardiac myocytes from dog ventricle is due to non-cardiac-type Na(+) channels. Biet M; Barajas-Martínez H; Ton AT; Delabre JF; Morin N; Dumaine R J Mol Cell Cardiol; 2012 Nov; 53(5):593-8. PubMed ID: 22759452 [TBL] [Abstract][Full Text] [Related]
31. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD BMC Gastroenterol; 2015 Oct; 15():134. PubMed ID: 26467777 [TBL] [Abstract][Full Text] [Related]
32. The effects of A-803467 on cardiac Nav1.5 channels. Han Z; Jiang Y; Xiao F; Cao K; Wang DW Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724 [TBL] [Abstract][Full Text] [Related]
33. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine. Wang Y; Mi J; Lu K; Lu Y; Wang K PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619 [TBL] [Abstract][Full Text] [Related]
34. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay. Qu Y; Gao B; Fang M; Vargas HM J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063 [TBL] [Abstract][Full Text] [Related]
35. Differential Inhibition of Neuronal Sodium Channel Subtypes by the General Anesthetic Isoflurane. Zhou C; Johnson KW; Herold KF; Hemmings HC J Pharmacol Exp Ther; 2019 May; 369(2):200-211. PubMed ID: 30792243 [TBL] [Abstract][Full Text] [Related]
36. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells. Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541 [TBL] [Abstract][Full Text] [Related]
37. Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels. Fischer F; Vonderlin N; Seyler C; Zitron E; Schernus B; Katus H; Scholz E Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):795-804. PubMed ID: 23666493 [TBL] [Abstract][Full Text] [Related]
38. The distinct effects of lipid emulsions used for "lipid resuscitation" on gating and bupivacaine-induced inhibition of the cardiac sodium channel Nav1.5. Nadrowitz F; Stoetzer C; Foadi N; Ahrens J; Wegner F; Lampert A; Koppert W; de la Roche J; Leffler A Anesth Analg; 2013 Nov; 117(5):1101-8. PubMed ID: 24029851 [TBL] [Abstract][Full Text] [Related]
39. Assessing use-dependent inhibition of the cardiac Na(+/-) current (I(Na)) in the PatchXpress automated patch clamp. Penniman JR; Kim DC; Salata JJ; Imredy JP J Pharmacol Toxicol Methods; 2010; 62(2):107-18. PubMed ID: 20601018 [TBL] [Abstract][Full Text] [Related]
40. Biophysical, Molecular, and Pharmacological Characterization of Voltage-Dependent Sodium Channels From Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Moreau A; Mercier A; Thériault O; Boutjdir M; Burger B; Keller DI; Chahine M Can J Cardiol; 2017 Feb; 33(2):269-278. PubMed ID: 27998617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]